#1QWithCNBCTV18 | #BhartiHexacom reports its Q1 results
Net Profit Up 23.19% At ₹482.4 Cr Vs ₹391.6 Cr (YoY)
Revenue Up 10.9% At ₹2,510 Cr Vs ₹2,263 Cr (YoY)
EBITDA Up 13.9% At ₹1,322.2 Cr Vs ₹1,160.7 Cr (YoY)
Margin At 52.68% Vs 51.29% (YoY)
#1QWithCNBCTV18 | #CastrolIndia reports its Q2 results;
Net Profit Up 42.50% At ₹347 Cr Vs ₹244 Cr (YoY)
Revenue Up 25% At ₹1,871 Cr Vs ₹1,497 Cr (YoY)
EBITDA Up 40.8% At ₹599.4 Cr Vs ₹425.7 Cr (YoY)
Margin At 32.03% Vs 28.44% (YoY)
#1QWithCNBCTV18 | #Marico reports its Q1 results;
Net profit Up 27% At ₹652 Cr Vs ₹513 Cr (YoY)
Revenue Up 23% At ₹3,957 Cr Vs ₹3,259 Cr (YoY)
EBITDA Up 25% At ₹819 Cr Vs ₹655 Cr (YoY)
Margin At 20.7% Vs 20.1% (YoY)
#1QWithCNBCTV18 | #Marico reports its Q1 results;
Profit At ₹652 Cr Vs CNBC-TV18 Poll Of ₹587 Cr
Revenue At ₹3,957 Cr Vs CNBC-TV18 Poll Of ₹3,927 Cr
EBITDA At ₹819 Cr Vs CNBC-TV18 Poll Of ₹776 Cr
Margin At 20.7% Vs CNBC-TV18 Poll Of 19.8%
#JustIn | #ZydusLife Gets Final US FDA Approval For Indocyanine Green For Injection With 180-day Exclusivity
Alert: Indocyanine Green Is A Fluorescent Dye Used In Medicine For Diagnostic Imaging, Blood Flow Checking, And Surgical Navigation
#1QWithCNBCTV18 | #HappyForgings reports its Q1 results;
Net profit Up 39.3% At ₹91.4 Cr Vs ₹65.7 Cr (YoY)
Revenue Up 27% At ₹449 Cr Vs ₹354 Cr (YoY)
EBITDA Up 39.3% At ₹141 Cr Vs ₹101 Cr (YoY)
Margin At 31.4% Vs 28.6% (YoY)
#JustIn | Sources Say
👉Govt Likely To Exercise Green Shoe Option For LIC OFS
👉LIC OFS Base Issue Is For 2.5% Stake, Greenshoe Option Is For An Addl 4% Stake
Alert: Non-retail Portion Has Seen A Strong Response & Is Oversubscribed
#1QWithCNBCTV18 | #Pidilite reports its Q1 results;
⏩Net Profit At ₹884 Cr Vs CNBC-TV18 Poll Of ₹774 Cr
⏩Revenue At ₹4,551 Cr Vs CNBC-TV18 Poll Of ₹4,446 Cr
⏩EBITDA At ₹1,194 Cr Vs CNBC-TV18 Poll Of ₹1,080 Cr
⏩Margin At 26.2% Vs CNBC-TV18 Poll Of 24.3%
⏩Domestic Overall Volume Growth At 11.3% Vs CNBC-TV18 Poll Of 11-12%
#1QWithCNBCTV18 | #BharatBijlee Q1
Net Profit Down 29.6% At ₹19.63 Cr Vs ₹27.88 Cr (YoY)
Revenue Up 17.7% At ₹547.17 Cr Vs ₹464.90 Cr (YoY)
EBITDA Down 14.3% At ₹28.82 Cr Vs ₹33.64 Cr (YoY)
Margin At 5.27% Vs 7.24% (YoY)
#1QWithCNBCTV18 | #AjmeraRealty reports its Q1 results;
Profit Up 12.5% At ₹43.1 Cr Vs ₹38.3 Cr (YoY)
Revenue Up 22.7% At ₹317.0 Cr Vs ₹258.4 Cr (YoY)
EBITDA Up 16.8% At ₹91.3 Cr Vs ₹78.2 Cr (YoY)
Margin At 28.8% Vs 30.2% (YoY)
#1QWithCNBCTV18 | #AlkylAmines reports its Q1 results;
Net Profit Up 91.4% At ₹94.6 Cr Vs ₹49.4 Cr (YoY)
Revenue Up 30.2% At ₹528.0 Cr Vs ₹405.5 Cr (YoY)
EBITDA Up 74.5% At ₹133.6 Cr Vs ₹76.6 Cr (YoY)
Margin At 25.3% Vs 18.9% (YoY)